Companies: 10,795·Total market cap: $144.5T

HLS Therapeutics Inc.

HLS Therapeutics Inc.

HLTRFOTCHealthcare● Active

$3.15

+$0.00(+0.00%)

Market Cap$98512155

P/E Ratio—

52W High$4.02

52W Low$3

Avg Volume166

Open$3.15

Beta0.85

股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

HLS Therapeutics Inc.（HLTRF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · HLTRF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.32Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$55.8MFull revenue history

Dividend Yield3.44%Dividend history

Shares Outstanding31.5MShares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

探索 HLS Therapeutics Inc. 数据

分析师预测$— · Hold

营收$56.5M-0.26%

盈利EPS $-0.40+35.48%

财务快照

FY 2025Revenue$56.5M▼ 0.26% YoY

202320242025

FY 2025Net Income-$12.6M▲ +35.65% YoY

202320242025

FY 2025EPS$-0.40▲ +35.48% YoY

202320242025

TTM:Revenue: $55.8MNet Income: -$10.3MEPS: $-0.32View income statement →

分析师评级与目标价

Hold1 位分析师

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$3.15Current

$—Avg Target

$—High

合计: 1 · 买入占比: 0.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

HLS Therapeutics Inc.

$3.15+0.00%$98.5M #2

Ascend Wellness Holdings, Inc.

$0.56+0.54%$114.3M #3

Auxly Cannabis Group Inc.

$0.11-5.17%$154.3M #4

Hofseth BioCare ASA

$0.17+0.00%$65.8M #5

Jushi Holdings Inc.

$0.53+5.37%$106.8M #6

Lumos Diagnostics Holdings Limited

$0.08-5.49%$59.1M

股票表现

1D+0.00%

1W+0.00%

1M-7.89%

3M-6.25%

YTD-8.16%

1Y-13.93%

5Y-78.88%

关于 HLS Therapeutics Inc.

CEOCraig Stuart Millian

IPO DateJan 27, 2010

Employees92

CountryCA

Websitehlstherapeutics.com

HLS Therapeutics Inc. is a specialized pharmaceutical firm engaged in the acquisition and commercialization of medicinal products, with a primary focus on the central nervous system (CNS) and cardiova…

Drug Manufacturers - Specialty & Generic HealthcareOTCCA

关于股票概览与关键数据

HLS Therapeutics Inc.（HLTRF）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Jan 27, 2010 在 OTC 上市。截至最近交易日，HLTRF 股价为 $3.15，市值约为 $98.5M。过去12个月累计回报 -13.93%，年初至今回报 -8.16%。

根据 1 位华尔街分析师，HLS Therapeutics Inc. 股票共识评级为Hold，12个月平均目标价为 $—。2025 财年 HLS Therapeutics Inc. 营收 $56.5M，净利润 -$12.6M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，HLS Therapeutics Inc.（HLTRF）股价为 $3.15，在 OTC 上市，52周区间为 $3.00 – $4.02。

HLTRF 最新股价HLTRF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议